These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study. Haas M, Delbello MP, Pandina G, Kushner S, Van Hove I, Augustyns I, Quiroz J, Kusumakar V. Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994 [Abstract] [Full Text] [Related]
5. Effectiveness and safety of risperidone for children and adolescents with chronic tic or tourette disorders in Korea. Kim BN, Lee CB, Hwang JW, Shin MS, Cho SC. J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):318-24. PubMed ID: 15910216 [Abstract] [Full Text] [Related]
7. Quetiapine for tic disorder: a case report. Chan-Ob T, Kuntawongse N, Boonyanaruthee V. J Med Assoc Thai; 2001 Nov; 84(11):1624-8. PubMed ID: 11853307 [Abstract] [Full Text] [Related]
16. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone. De Deyn PP, Katz IR, Brodaty H, Lyons B, Greenspan A, Burns A. Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506 [Abstract] [Full Text] [Related]
17. Risperidone as a treatment for Tourette's syndrome. Bruun RD, Budman CL. J Clin Psychiatry; 1996 Jan; 57(1):29-31. PubMed ID: 8543544 [Abstract] [Full Text] [Related]
18. Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study. Cubo E, Fernández Jaén A, Moreno C, Anaya B, González M, Kompoliti K. Clin Ther; 2008 Jan; 30(1):182-9. PubMed ID: 18343255 [Abstract] [Full Text] [Related]